ICM
MD icon

Invenomic Capital Management’s Pediatrix Medical MD Stock Holding History

Invenomic Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-285,906
Closed -$4.1M – 165
2025
Q2 		$4.1M Buy
+285,906
New +$3.92M 0.23% 109
2024
Q4 		– Sell
-780,983
Closed -$9.05M – 174
2024
Q3 		$9.05M Sell
780,983
-151,125
-16% -$1.42M 0.5% 67
2024
Q2 		$7.04M Sell
932,108
-40,741
-4% -$337K 0.34% 85
2024
Q1 		$9.76M Sell
972,849
-405,102
-29% -$3.77M 0.52% 69
2023
Q4 		$12.8M Buy
1,377,951
+664,955
+93% +$6.88M 0.58% 59
2023
Q3 		$9.06M Buy
712,996
+312,778
+78% +$4.29M 0.38% 73
2023
Q2 		$5.69M Sell
400,218
-13,705
-3% -$192K 0.29% 81
2023
Q1 		$6.17M Buy
+413,923
New +$6.27M 0.35% 81

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invenomic Capital Management's MD Position: Q3 2025 in Review

Invenomic Capital Management sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 285,906 shares — an estimated $4.1M sold.

Invenomic Capital Management first reported a position in MD in Q1 2023 and held it in 8 quarters. The position peaked at $12.8M in Q4 2023. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

  • Invenomic Capital Management reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 285,906 Pediatrix Medical shares in Q3 2025, an estimated $4.1M.
  • Invenomic Capital Management first reported a position in Pediatrix Medical in Q1 2023 and held it in 8 quarters.
  • Invenomic Capital Management's Pediatrix Medical position peaked at $12.8M in Q4 2023.
  • 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.